Upcoming webinar

Advancing the CMC Development of Oncology Medicines

How do I select the right formulation for my molecule?

Quotient is your answer.

Formulation development

Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development.

Formulation experience across a full breadth of dosage forms

From preclinical and first-in-human (FIH) dosage forms to optimization of your drug product for late-stage development and market following clinical evaluation, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your drug molecule, the intended route of administration and the phase of development.

With our state-of-the-art facilities in the U.S. and U.K., we offer you a formulation development service that draws on the extensive experience of our formulation and biopharmaceutics scientists to identify the phase appropriate, optimal formulation of your molecule. Our industry leading project managers and scientists will provide end-to-end support across our global sites, making drug development easier for our customers and dramatically reducing the time and cost of getting new medicines to patients.

Get in touch to find out how Quotient Sciences can put speed, precision and quality at the heart of your pipeline

Connect With Quotient

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.